Assertio Therapeutics's total assets for Q1 2026 were $211.30M, a decrease of -20.85% from the previous quarter. ASRT total liabilities were $135.67M for the fiscal quarter, a -21.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.